Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
Status:
Withdrawn
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of AZD1236 in patients with cystic
fibrosis (CF) on inflammatory biomarkers in induced sputum, after a treatment period of 4
weeks.